Electromed, Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Electromed, Inc. (ELMD) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $23.95 per share for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-25.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2026-08-25
- Electromed, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2025-09-30 was $23.95.
- Electromed, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2026 was $23.95, a 37.41% increase from fiscal 2025.
- Electromed, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2025 was $17.43, a 62.90% increase from fiscal 2024.
- Electromed, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2024 was $10.70.
- Electromed, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2015 was $1.40, a 6.87% increase from fiscal 2014.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 1 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $23.95 10-K · filed 2026-08-25 | ||||
| 2026-03-31 | $23.95 10-Q · filed 2026-05-12 | ||||
| 2025-12-31 | $23.95 10-Q · filed 2026-02-10 | ||||
| 2025-09-30 | $23.95 10-Q · filed 2025-11-12 | ||||
| 2025-06-30 | $17.43 10-K · filed 2026-08-25 | ||||
| 2024-06-30 | $10.70 10-K · filed 2025-08-26 | ||||
| 2024-03-31 | $17.43 10-Q · filed 2025-05-13 | ||||
| 2021-12-31 | $11.40 10-Q · filed 2022-02-08 | ||||
| 2015-06-30 | $1.40 10-K · filed 2015-09-15 | ||||
| 2014-06-30 | $1.31 10-K · filed 2015-09-15 | ||||
| 2013-06-30 | $1.67 10-K · filed 2014-09-23 | ||||
| 2012-06-30 | $2.90 10-K · filed 2013-09-25 | ||||
| 2011-06-30 | $4.50 10-K · filed 2012-09-26 | ||||
| 2010-08-31 | $4.80 10-K · filed 2017-09-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EDAP TMS SA (FOCL) | $0.171B | ||
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B |